Our MR analysis did not indicate a causal effect of genetically predicted adiponectin levels on SSc risk; however, it does provide evidence that a genetic liability to SSc causally contributes to lower circulating adiponectin levels. The gene discussed is ADIPOQ; the disease is systemic sclerosis.